| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |